Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

05. Dezember 2025 08:18 ET | Quelle: Bleichmar Fonti & Auld

MoonLake Immunotherapeutics (MLTX) Investors are Encouraged to Act before the Upcoming December 15 Securities Fraud Deadline – Contact BFA Law if You Lost Money

MoonLake Immunotherapeutics (MLTX) Investors are Encouraged to Act before the Upcoming December 15 Securities Fraud Deadline – Contact BFA Law
19. November 2025 08:08 ET | Quelle: Bleichmar Fonti & Auld

MLTX STOCK: MoonLake Immunotherapeutics Sued for Securities Fraud after Drug Trial Results Cause 90% Stock Drop -- Investors Notified to Contact BFA Law

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA before the December 15, 2025 securities fraud class action deadline.
29. September 2025 18:20 ET | Quelle: Bleichmar Fonti & Auld

MLTX BREAKING NEWS: BFA Law is Investigating MoonLake Immunotherapeutics (NASDAQ: MLTX) for Securities Fraud after Stock Drops 90% on Drug Trial Results, Investors Urged to Contact the Firm

MoonLake Immunotherapeutics investors that lost money on their investment are encouraged to contact BFA Law about their rights.
18. August 2022 09:00 ET | Quelle: University of Minnesota Medical School

COVID OUT clinical trial suggests metformin effective at reducing odds of serious outcomes for COVID-19 patients seeking early treatment

MINNEAPOLIS/ST. PAUL, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Published in the New England Journal of Medicine, researchers — led by the University of Minnesota Medical School and School of Public Health...